PLRZ Stock Catalyst: Polyrizon Ltd. Reports Successful Preclinical Results for PL-14 Allergy Blocker

Jul 21, 2025 · 7:59pm ET

Demonstrated over 60% targeted nasal deposition in the nasal vestibule.

Max move

+107.8%

High of day $11.22

Sparker timei

7:59pm ET

PLRZ · Jul 21, 2025

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Polyrizon Ltd. (Nasdaq: PLRZ) announced on July 22, 2025, that its PL-14 Allergy Blocker achieved successful preclinical results. The study demonstrated over 60% targeted nasal deposition in the nasal vestibule.

The preclinical results indicate a significant achievement in the development of the PL-14 Allergy Blocker, showcasing its potential efficacy in targeted nasal delivery.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time PLRZ sparks.

Download Sniper App →

Catch the next PLRZ-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →